These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27513345)

  • 1. Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient.
    Mühlstädt M
    Dermatology; 2016; 232 Suppl 1():20-3. PubMed ID: 27513345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
    Zane C; Fabiano A; Arisi M; Calzavara-Pinton P
    Dermatology; 2016; 232(4):472-7. PubMed ID: 27578305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
    Moggio E; Arisi M; Zane C; Calzavara-Pinton I; Calzavara-Pinton P
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():161-165. PubMed ID: 27530375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight photodynamic therapy for field cancerization: lessons from molecular biology.
    Rybarski M; Schmitz L; Novak B; Dirschka T
    G Ital Dermatol Venereol; 2018 Dec; 153(6):806-810. PubMed ID: 29683291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingenol Mebutate and the Treatment of Actinic Keratosis.
    Heron CE; Feldman SR
    J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization.
    Gaide O; Clayton H; Girardin M; Kuonen F
    Dermatology; 2016; 232 Suppl 1():7-8. PubMed ID: 27513862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
    Fai D; Romano I; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
    Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
    J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin.
    Torezan L; Chaves Y; Niwa A; Sanches JA; Festa-Neto C; Szeimies RM
    Dermatol Surg; 2013 Aug; 39(8):1197-201. PubMed ID: 23638986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
    Jansen MHE; Kessels JPHM; Nelemans PJ; Kouloubis N; Arits AHMM; van Pelt HPA; Quaedvlieg PJF; Essers BAB; Steijlen PM; Kelleners-Smeets NWJ; Mosterd K
    N Engl J Med; 2019 Mar; 380(10):935-946. PubMed ID: 30855743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
    Wenande E; Phothong W; Bay C; Karmisholt KE; Haedersdal M; Togsverd-Bo K
    Br J Dermatol; 2019 Apr; 180(4):756-764. PubMed ID: 30117140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.